Novavax (NVAX) Misses Q4 EPS by $1.09
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $10.11 --0%
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q4 EPS of ($2.28), $1.09 worse than the analyst estimate of ($1.19). Revenue for the quarter came in at $357 million versus the consensus estimate of $383.14 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Faraday Future unveils nine robotics devices priced from $9,990
- Equinox Gold to redeem $172.5M in convertible notes in October
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
